Detalhe da pesquisa
1.
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study.
Mov Disord
; 37(7): 1516-1525, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607776
2.
Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study.
BMC Neurol
; 17(1): 129, 2017 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28676085
3.
Short-term Tolerance of Nasally-administered NeuroEPO in Patients with Parkinson Disease.
MEDICC Rev
; 23(1): 49-54, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33780423